ARTICLE | Clinical News
Picoplatin: Additional Phase II data
March 15, 2010 7:00 AM UTC
Additional data from a Phase II trial in 29 evaluable patients showed that picoplatin in combination with docetaxel and prednisone led to a median OS of 21.4 months compared to 18.9 months for patient...